Lixte Biotechnology Holdings Inc Cash Flow-to-Debt Ratio
Lixte Biotechnology Holdings Inc cash flow-to-debt ratio. Lixte Biotechnology Holdings Inc (LIXT) has a Cash Flow-to-Debt Ratio of -1.09x as of March 2026, meaning its operating cash flow of $-1.83 Million could theoretically repay -1% of its total liabilities ($1.69 Million) in one year. Check Lixte Biotechnology Holdings Inc (LIXT) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Lixte Biotechnology Holdings Inc (2005–2025)
Cash flow-to-debt ratio of Lixte Biotechnology Holdings Inc from 2005 to 2025. Historical debt coverage capacity for Lixte Biotechnology Holdings Inc across 21 annual periods. Also explore net asset growth rate of Lixte Biotechnology Holdings Inc to track the company's year-over-year net asset growth rate.
Lixte Biotechnology Holdings Inc Cash Flow-to-Debt Ratio by Year (2005–2025)
Lixte Biotechnology Holdings Inc cash flow-to-debt ratio by year from 2005 to 2025. Year-by-year debt coverage analysis for Lixte Biotechnology Holdings Inc. For the full cash flow conversion analysis, see LIXT cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.73x | $-3.07 Million | $1.77 Million | ▲ +82.6% |
| 2024 | -9.94x | $-3.16 Million | $318.28K | ▲ +27.3% |
| 2023 | -13.68x | $-4.29 Million | $313.86K | ▼ -17.1% |
| 2022 | -11.68x | $-4.61 Million | $394.79K | ▲ +14.6% |
| 2021 | -13.68x | $-4.14 Million | $302.93K | ▼ -38.9% |
| 2020 | -9.84x | $-2.13 Million | $216.52K | ▼ -39.9% |
| 2019 | -7.04x | $-1.67 Million | $237.90K | ▲ +1.8% |
| 2018 | -7.16x | $-1.51 Million | $210.91K | ▼ -89.2% |
| 2017 | -3.79x | $-1.41 Million | $373.02K | ▲ +50.7% |
| 2016 | -7.67x | $-1.68 Million | $218.65K | ▼ -0.5% |
| 2015 | -7.64x | $-2.18 Million | $285.64K | ▼ -27.7% |
| 2014 | -5.98x | $-1.64 Million | $273.44K | ▼ -63.1% |
| 2013 | -3.67x | $-1.18 Million | $321.77K | ▲ +20.6% |
| 2012 | -4.62x | $-1.21 Million | $261.15K | ▼ -19.1% |
| 2011 | -3.88x | $-1.36 Million | $350.75K | ▲ +19.2% |
| 2010 | -4.80x | $-936.39K | $195.06K | ▼ -125.8% |
| 2009 | -2.13x | $-638.44K | $300.26K | ▼ -33.5% |
| 2008 | -1.59x | $-597.69K | $375.20K | ▲ +42.8% |
| 2007 | -2.79x | $-702.87K | $252.18K | ▲ +21.7% |
| 2006 | -3.56x | $-443.45K | $124.50K | ▼ -35.5% |
| 2005 | -2.63x | $-32.87K | $12.50K | — |